Boom Times For Autoimmune Disease Therapies

The autoimmune disease therapy market is experiencing a boom, with major developments including OpenAI's healthcare push and Vertex's $10 billion acquisition of Crinetics, signaling significant investment and innovation in the sector.

Boom Times For Autoimmune Disease Therapies By Amy Feldman, Forbes StaffSource: Forbes Innovation https://www.forbes.com/innovation/ In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion purchase of Crinetics, and more. In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI /glossary/openai ’s healthcare push, Vertex’s $10 billion purchase of Crinetics, and more.Get AI news in your inbox Daily digest of what matters in AI.